| Id |
Subject |
Object |
Predicate |
Lexical cue |
| TextSentencer_T1 |
0-124 |
Sentence |
denotes |
Cutting edge: autoimmune disease risk variant of STAT4 confers increased sensitivity to IFN-alpha in lupus patients in vivo. |
| T1 |
0-124 |
Sentence |
denotes |
Cutting edge: autoimmune disease risk variant of STAT4 confers increased sensitivity to IFN-alpha in lupus patients in vivo. |
| TextSentencer_T2 |
125-224 |
Sentence |
denotes |
Increased IFN-alpha signaling is a primary pathogenic factor in systemic lupus erythematosus (SLE). |
| T2 |
125-224 |
Sentence |
denotes |
Increased IFN-alpha signaling is a primary pathogenic factor in systemic lupus erythematosus (SLE). |
| TextSentencer_T3 |
225-392 |
Sentence |
denotes |
STAT4 is a transcription factor that is activated by IFN-alpha signaling, and genetic variation of STAT4 has been associated with risk of SLE and rheumatoid arthritis. |
| T3 |
225-392 |
Sentence |
denotes |
STAT4 is a transcription factor that is activated by IFN-alpha signaling, and genetic variation of STAT4 has been associated with risk of SLE and rheumatoid arthritis. |
| TextSentencer_T4 |
393-511 |
Sentence |
denotes |
We measured serum IFN-alpha activity and simultaneous IFN-alpha-induced gene expression in PBMC in a large SLE cohort. |
| T4 |
393-511 |
Sentence |
denotes |
We measured serum IFN-alpha activity and simultaneous IFN-alpha-induced gene expression in PBMC in a large SLE cohort. |
| TextSentencer_T5 |
512-709 |
Sentence |
denotes |
The risk variant of STAT4 (T allele; rs7574865) was simultaneously associated with both lower serum IFN-alpha activity and greater IFN-alpha-induced gene expression in PBMC in SLE patients in vivo. |
| T5 |
512-709 |
Sentence |
denotes |
The risk variant of STAT4 (T allele; rs7574865) was simultaneously associated with both lower serum IFN-alpha activity and greater IFN-alpha-induced gene expression in PBMC in SLE patients in vivo. |
| TextSentencer_T6 |
710-835 |
Sentence |
denotes |
Regression analyses confirmed that the risk allele of STAT4 was associated with increased sensitivity to IFN-alpha signaling. |
| T6 |
710-835 |
Sentence |
denotes |
Regression analyses confirmed that the risk allele of STAT4 was associated with increased sensitivity to IFN-alpha signaling. |
| TextSentencer_T7 |
836-1022 |
Sentence |
denotes |
The IFN regulatory factor 5 SLE risk genotype was associated with higher serum IFN-alpha activity; however, STAT4 showed dominant influence on the sensitivity of PBMC to serum IFN-alpha. |
| T7 |
836-1022 |
Sentence |
denotes |
The IFN regulatory factor 5 SLE risk genotype was associated with higher serum IFN-alpha activity; however, STAT4 showed dominant influence on the sensitivity of PBMC to serum IFN-alpha. |
| TextSentencer_T8 |
1023-1124 |
Sentence |
denotes |
These data provide biologic relevance for the risk variant of STAT4 in the IFN-alpha pathway in vivo. |
| T8 |
1023-1124 |
Sentence |
denotes |
These data provide biologic relevance for the risk variant of STAT4 in the IFN-alpha pathway in vivo. |